Clinical dermatology company Botanix Pharmaceuticals is tapping investors for $13.5 million to help fund the commercial launch of its lead treatment.
Clinical dermatology company Botanix Pharmaceuticals is tapping investors for $13.5 million to help fund the commercial launch of its lead treatment.